Literature DB >> 26256188

Inclusion complexes of chlorzoxazone with β- and hydroxypropyl-β-cyclodextrin: Characterization, dissolution, and cytotoxicity.

Peixiao Tang1, Shanshan Li1, Lili Wang1, Hongqin Yang1, Jin Yan1, Hui Li2.   

Abstract

This study aimed to improve the water solubility and reduce the toxicity of chlorzoxazone via complexation with β-cyclodextrin (β-CD) and hydroxypropyl-β-cyclodextrin (HP-β-CD). Inclusion complexes between chlorzoxazone and the two cyclodextrins (CDs) were prepared by freeze-drying method. Formation of the complexes was confirmed by FT-IR, PXRD, (1)H NMR, DSC, and SEM. The water solubility and dissolution rates of chlorzoxazone were significantly increased by complexation with the two CDs. Preliminary in vitro cytotoxicity tests showed that the complexes are less toxic to normal liver cells than free chlorzoxazone. In general, the HP-β-CD complex exhibited better dissolution properties than the β-CD complex in various dissolution media. Therefore, the HP-β-CD complex can be used to design novel formulations of chlorzoxazone.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chlorzoxazone; Chlorzoxazone (PubChem CID: 2733); Dimethyl sulfoxide (PubChem CID: 679); Hydroxypropyl-beta-cyclodextrin (PubChem CID: 14049689); Hydroxypropyl-β-cyclodextrin; In vitro cytotoxicity; Inclusion complex; Methanol (PubChem CID: 887); Solubilization; β-Cyclodextrin; β-Cyclodextrin (PubChem CID: 444041)

Mesh:

Substances:

Year:  2015        PMID: 26256188     DOI: 10.1016/j.carbpol.2015.05.055

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  7 in total

Review 1.  Advances in the use of functional composites of β-cyclodextrin in electrochemical sensors.

Authors:  Xiaohui Niu; Zunli Mo; Xing Yang; Mingyuan Sun; Pan Zhao; Zhenliang Li; Meixuan Ouyang; Zhenyu Liu; Huhu Gao; Ruibin Guo; Nijuan Liu
Journal:  Mikrochim Acta       Date:  2018-06-16       Impact factor: 5.833

2.  β-Caryophyllene/Hydroxypropyl-β-Cyclodextrin Inclusion Complex Improves Cognitive Deficits in Rats with Vascular Dementia through the Cannabinoid Receptor Type 2 -Mediated Pathway.

Authors:  Jie Lou; Zhipeng Teng; Liangke Zhang; Jiadan Yang; Lianju Ma; Fang Wang; Xiaocui Tian; Ruidi An; Mei Yang; Qian Zhang; Lu Xu; Zhi Dong
Journal:  Front Pharmacol       Date:  2017-01-19       Impact factor: 5.810

3.  Rational formulation engineering of fraxinellone utilizing 6-O-α-D-maltosyl-β-cyclodextrin for enhanced oral bioavailability and hepatic fibrosis therapy.

Authors:  Jianbo Li; Tiange Feng; Weijing Yang; Yaru Xu; Shuaishuai Wang; Huijie Cai; Zhilei Liu; Hong Qiang; Jinjie Zhang
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

4.  Cyclodextrin and its derivatives as effective excipients for amorphous ulipristal acetate systems.

Authors:  Peng Wang; Yan Wang; Zili Suo; Yuanming Zhai; Hui Li
Journal:  RSC Adv       Date:  2022-03-23       Impact factor: 3.361

5.  Interactions between β-cyclodextrin and tea catechins, and potential anti-osteoclastogenesis activity of the (-)-epigallocatechin-3-gallate-β-cyclodextrin complex.

Authors:  Huanhuan Xu; Titi Liu; Jing Xu; Jin Li; Fei Chen; Zemin Xiang; Yewei Huang; Dongying Zhang; Lihong Hu; Banglei Zhang; Chengting Zi; Xuanjun Wang; Jun Sheng
Journal:  RSC Adv       Date:  2019-09-06       Impact factor: 4.036

6.  Aurisin A Complexed with 2,6-Di-O-methyl-β-cyclodextrin Enhances Aqueous Solubility, Thermal Stability, and Antiproliferative Activity against Lung Cancer Cells.

Authors:  Thanapon Charoenwongpaiboon; Amy Oo; Sutita Nasoontorn; Thanyada Rungrotmongkol; Somdej Kanokmedhakul; Panupong Mahalapbutr
Journal:  Int J Mol Sci       Date:  2022-08-29       Impact factor: 6.208

7.  Quantitative prediction of the bitterness of atomoxetine hydrochloride and taste-masked using hydroxypropyl-β-cyclodextrin: A biosensor evaluation and interaction study.

Authors:  Shuying Li; Ying Zhang; Abdur Rauf Khan; Shuwang He; Yingxin Wang; Jiangkang Xu; Guangxi Zhai
Journal:  Asian J Pharm Sci       Date:  2019-11-26       Impact factor: 6.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.